TTM Inc. is developing patented technology that is expected to replace all existing Targeted Temperature Management Systems and revolutionize the way we treat injuries such as cardiac arrest, stroke, neonatal hypoxic encephalopathy, cerebral edema, and ARDS (acute respiratory distress syndrome). Many hospitals have stopped using Therapeutic Hypothermia due to the lack of effectiveness of currently available devices. Our patented TTMS developed by Sergei Shushunov, MD, presents a new method of inducing, maintaining and reversing hypothermia that works on the principle of delivering hyper-cold air through a mechanical or manual ventilator. It is a simple, easy to use, and portable device that will expand the use of hypothermia equipment to pre-hospital settings, such as ground and air ambulances, as well as military field hospitals. In addition, we have developed a prototype for a new resuscitation ventilator that will drastically improve CPR outcomes for victims of sudden cardiac arrest. It operates in synchrony with chest compressions to augment blood flow, and consists of dual chambers that work to negate compression variability and improve venous blood flow. Traditional CPR has reached a plateau, and we believe it will take a fundamental change to the entire process to make CPR more effective. Join us in our mission to revolutionize critical care and save millions of lives. We are now seeking to conduct a proof of concept laboratory study, and are open to partnerships with medical equipment manufacturing companies. Visit our website for more information about the market potential of our patented technology. hypothermiatherapy.com